Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Topical calcipotriol for psoriasis--an immunohistologic study

N Mozzanica1, A Cattaneo, E Schmitt

  • 1Department of Dermatology, University of Milan, Italy.

Acta Dermato-Venereologica. Supplementum
|January 1, 1994
PubMed
Summary

Topical calcipotriol treatment for psoriasis modulates immune cells and reduces keratinocyte activation markers, leading to moderate clinical improvement. This study highlights calcipotriol's early immunomodulatory effects in psoriasis lesions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Understanding, predicting, and treating depression in pregnancy to improve mothers' and offspring's mental health outcomes: The HappyMums study.

Brain, behavior, & immunity - health·2025
Same author

Preliminary observations on tear film interferometry performed in horses.

Journal of equine veterinary science·2024
Same author

Serum concentration-guided intravenous magnesium sulfate administration for neuroprotection in patients with aneurysmal subarachnoid hemorrhage: a retrospective evaluation of a 12-year single-center experience.

Neurosurgical review·2023
Same author

Author Correction: Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.

NPJ Parkinson's disease·2023
Same author

Exposure to chronic stress impairs the ability to cope with an acute challenge: Modulation by lurasidone treatment.

European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology·2022
Same author

Enteric α-synuclein impairs intestinal epithelial barrier through caspase-1-inflammasome signaling in Parkinson's disease before brain pathology.

NPJ Parkinson's disease·2022

Area of Science:

  • Dermatology
  • Immunology
  • Cell Biology

Background:

  • Psoriasis involves immune cell infiltration and keratinocyte activation.
  • Langerhans cells and T cells play crucial roles in psoriatic skin lesions.
  • Understanding treatment effects on cellular markers is key to managing psoriasis.

Purpose of the Study:

  • To investigate the distribution of Langerhans cells and T cells in psoriatic lesions.
  • To analyze phenotypic expression of activation markers on lesional T cells and keratinocytes.
  • To evaluate changes before and after topical calcipotriol treatment.

Main Methods:

  • Studied 7 psoriatic patients before and after 2 weeks of topical calcipotriol.
  • Assessed Langerhans cells (CD1 expression) and T cells (CD4 expression).

Related Experiment Videos

  • Examined keratinocyte markers: ICAM-1, EGF receptor, and Transferrin receptor.

    • Main Results:

    • Calcipotriol treatment reduced dermal CD4+ T cells and increased intraepidermal CD1+ Langerhans cells.
    • ICAM-1 expression on keratinocytes decreased significantly in all patients.
    • EGF receptor expression reduced in some patients; Transferrin receptor expression unchanged.

    Conclusions:

    • Calcipotriol exhibits early immunomodulatory effects in psoriasis.
    • Treatment leads to decreased T cell infiltrate and altered Langerhans cell distribution.
    • Variable reduction in keratinocyte activation markers correlates with clinical improvement.